Alfaidi M, Barker R, Kuan W
J Neurol. 2024; 272(1):21.
PMID: 39666171
PMC: 11638298.
DOI: 10.1007/s00415-024-12770-x.
Petrijan T, Zmazek J, Menih M
J Clin Med. 2023; 12(23).
PMID: 38068486
PMC: 10707127.
DOI: 10.3390/jcm12237434.
Deidda G, Biazzo M
Front Neurosci. 2021; 15:753915.
PMID: 34712115
PMC: 8545893.
DOI: 10.3389/fnins.2021.753915.
LaiGuan Zoey F, Palanivel M, Padmanabhan P, Gulyas B
Front Cell Dev Biol. 2021; 9:707441.
PMID: 34490255
PMC: 8418352.
DOI: 10.3389/fcell.2021.707441.
Metta V, Batzu L, Leta V, Trivedi D, Powdleska A, Mridula K
J Pers Med. 2021; 11(7).
PMID: 34357147
PMC: 8305099.
DOI: 10.3390/jpm11070680.
Parkinson's Disease and the Gut: Symptoms, Nutrition, and Microbiota.
Yemula N, Dietrich C, Dostal V, Hornberger M
J Parkinsons Dis. 2021; 11(4):1491-1505.
PMID: 34250955
PMC: 8609682.
DOI: 10.3233/JPD-212707.
Neurodegenerative disorders and gut-brain interactions.
Singh A, Dawson T, Kulkarni S
J Clin Invest. 2021; 131(13).
PMID: 34196307
PMC: 8245172.
DOI: 10.1172/JCI143775.
Agitation and impulsivity in mid and late life as possible risk markers for incident dementia.
Bateman D, Gill S, Hu S, Foster E, Ruthirakuhan M, Sellek A
Alzheimers Dement (N Y). 2020; 6(1):e12016.
PMID: 32995467
PMC: 7507499.
DOI: 10.1002/trc2.12016.
Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease.
Fields C, Bengoa-Vergniory N, Wade-Martins R
Front Mol Neurosci. 2019; 12:299.
PMID: 31866823
PMC: 6906193.
DOI: 10.3389/fnmol.2019.00299.
The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease.
Yang D, Zhao D, Shah S, Wu W, Lai M, Zhang X
Front Neurol. 2019; 10:1155.
PMID: 31781020
PMC: 6851172.
DOI: 10.3389/fneur.2019.01155.
Role of MicroRNAs in Parkinson's Disease.
Goh S, Chao Y, Dheen S, Tan E, Tay S
Int J Mol Sci. 2019; 20(22).
PMID: 31718095
PMC: 6888719.
DOI: 10.3390/ijms20225649.
Probiotics for Parkinson's Disease.
Gazerani P
Int J Mol Sci. 2019; 20(17).
PMID: 31450864
PMC: 6747430.
DOI: 10.3390/ijms20174121.
T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
Campos-Acuna J, Elgueta D, Pacheco R
Front Immunol. 2019; 10:239.
PMID: 30828335
PMC: 6384270.
DOI: 10.3389/fimmu.2019.00239.
Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.
Poirier A, Aube B, Cote M, Morin N, Di Paolo T, Soulet D
Parkinsons Dis. 2017; 2016:6762528.
PMID: 28050310
PMC: 5168460.
DOI: 10.1155/2016/6762528.
The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study Group.
Kwon D, Koh S, Lee J, Park H, Kim H, Shin H
J Clin Neurol. 2016; 12(4):393-402.
PMID: 27819413
PMC: 5063863.
DOI: 10.3988/jcn.2016.12.4.393.
The Alterations of Cortical Volume, Thickness, Surface, and Density in the Intermediate Sporadic Parkinson's Disease from the Han Population of Mainland China.
Deng X, Zhou M, Tang C, Zhang J, Zhu L, Xie Z
Front Aging Neurosci. 2016; 8:185.
PMID: 27536237
PMC: 4971022.
DOI: 10.3389/fnagi.2016.00185.
Brain-derived neurotrophic factor serum levels correlate with cognitive performance in Parkinson's disease patients with mild cognitive impairment.
Costa A, Peppe A, Carlesimo G, Zabberoni S, Scalici F, Caltagirone C
Front Behav Neurosci. 2015; 9:253.
PMID: 26441580
PMC: 4569860.
DOI: 10.3389/fnbeh.2015.00253.
Many Faces of Parkinson's Disease: Non-Motor Symptoms of Parkinson's Disease.
Lee H, Koh S
J Mov Disord. 2015; 8(2):92-7.
PMID: 26090081
PMC: 4460545.
DOI: 10.14802/jmd.15003.
Mapping cortical atrophy in Parkinson's disease patients with dementia.
Hwang K, Beyer M, Green A, Chung C, Thompson P, Janvin C
J Parkinsons Dis. 2013; 3(1):69-76.
PMID: 23938313
PMC: 4018208.
DOI: 10.3233/JPD-120151.